Abstrakt

Przypisy

• 1. Bhullar M., Macrae F., Brown G., Smith M., Sharpe K.: Prediction ofCrohn’s disease aggression through NOD2/CARD15 gene sequencingin an Australian cohort. World J. Gastroenterol., 2014; 20: 5008-5016 doi: 10.3748/wjg.v20.i17.5008
  View Article  •   Google Scholar
• 2. Cuthbert A.P., Fisher S.A., Mirza M.M., King K., Hampe J., CroucherP.J., Mascheretti S., Sanderson J., Forbes A., Mansfield J., SchreiberS., Lewis C.M., Mathew C.G.: The contribution of NOD2 gene mutationsto the risk and site of disease in inflammatory bowel disease.Gastroenterology, 2002; 122: 867-874 doi: 10.1053/gast.2002.32415
  View Article  •   Google Scholar
• 3. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J.,Fukase K., Inamura S., Kusumoto S., Hashimoto M., Foster S.J., MoranA.P., Fernandez-Luna J.L., Nuñez G.: Host recognition of bacterialmuramyl dipeptide mediated through NOD2, Implications forCrohn`s disease. J. Biol. Chem., 2003; 278: 5509-5512 doi: 10.1074/jbc.c200673200
  View Article  •   Google Scholar
• 4. Inohara N., Ogura Y., Nunez G.: Nods: a family of cytosolic proteinsthat regulate the host response to pathogens. Curr. Opin. Microbiol.,2002; 5: 76-80 doi: 10.1016/s1369-5274(02)00289-8
  View Article  •   Google Scholar
• 5. Lesage S., Zouali H., Cézard J.P., Colombel J.F., Belaiche J., AlmerS., Tysk C., O’Morain C., Gassull M., Binder V., Finkel Y., ModiglianiR., Gower-Rousseau C., Macry J., Merlin F., Chamaillard M., JasnotA.S., Thomas G., Hugot J.P.; EPWG-IBD Group; EPIMAD Group; GETAIDGroup: CARD15/NOD2 mutational analysis and genotype-phenotypecorrelation in 612 patients with inflammatory bowel disease. Am. J.Hum. Genet., 2002; 70: 845-857 doi: 10.1086/339432
  View Article  •   Google Scholar
• 6. Li C., Kuemmerle J.F.: Mechanisms that mediate the developmentof fibrosis in patients with Crohn’s disease. Inflamm. BowelDis., 2014; 20: 1250-1258 doi: 10.1097/mib.0000000000000043
  View Article  •   Google Scholar
• 7. Neubauer K., Arlukiewicz A., Paradowski L.: Quality of life ininflammatory bowel disease. Adv. Clin. Exp. Med., 2009; 18: 79-83 doi: 10.1002/ibd.20582
  View Article  •   Google Scholar
• 8. Ogura Y., Inohara N., Benito A., Chen F.F., Yamaoka S., Nunez G.:Nod2, a Nod1/Apaf-1 family member that is restricted to monocytesand activates NF-κB. J. Biol. Chem., 2001; 276: 4812-4818 doi: 10.1074/jbc.m008072200
  View Article  •   Google Scholar
• 9. Ogura Y., Lala S., Xin W., Smith E., Dowds T.A., Chen F.F., ZimmermannE., Tretiakova M., Cho J.H., Hart J., Greenson J.K., KeshavS., Nuñez G.: Expression of NOD2 in Paneth cells: a possible link toCrohn`s ileitis. Gut, 2003; 52: 1591-1597 doi: 10.1136/gut.52.11.1591
  View Article  •   Google Scholar
• 10. Rosenstiel P., Fantini M., Bräutigam K., Kühbacher T., WaetzigG.H., Seegert D., Schreiber S.: TNF-α and IFN-γ regulate the expressionof the NOD2 (CARD15) gene in human intestinal epithelial cells,Gastroenterology. 2003; 124: 1001-1009 doi: 10.1053/gast.2003.50157
  View Article  •   Google Scholar
• 11. Sadakierska-Chudy A., Neubauer K., Poniewierka E.: The geneticbackground of Crohn›s disease – basic genetic definitions and thegene CARD15. Adv. Clin. Exp. Med., 2007; 16: 690-697 doi: 10.5604/17322693.1192187
  View Article  •   Google Scholar
• 12. Shivananda S., Leonard-Jones J., Logan R., Fear N., Price A., CarpenterL., van Blankenstein M.; EC-IBD Study Group: Incidence ofinflammatory bowel disease across Europe: is there a difference betweennorth and south? Results of the European Collaborative Studyon Inflammatory Bowel Disease (EC-IBD). Gut, 1996; 39: 690-697 doi: 10.1136/gut.39.5.690
  View Article  •   Google Scholar
• 13. Tsianos E.V., Katsanos K.H., Tsianos V.E.: Role of genetics in thediagnosis and prognosis of Crohn’s disease. World J. Gastroenterol.,2012; 18: 105-118 doi: 10.3748/wjg.v18.i2.105
  View Article  •   Google Scholar
• 14. Tysk C., Lindberg E., Järnerot G., Flodérus-Myrhed B.: Ulcerativecolitis and Crohn`s disease in an unselected population of monozygoticand dizygotic twins. A study of heritability and the influenceof smoking. Gut, 1988; 29: 990-996 doi: 10.1136/gut.29.7.990
  View Article  •   Google Scholar
• 15. Weiss B., Lebowitz O., Fidder H.H., Maza I., Levine A., Shaoul R.,Reif S., Bujanover Y., Karban A.: Response to medical treatment inpatients with Crohn’s disease: the role of NOD2/CRAD15, diseasephenotype, and age of diagnosis. Dig. Dis. Sci., 2010; 55: 1674-1680 doi: 10.1007/s10620-009-0936-8
  View Article  •   Google Scholar

Pełna treść artykułu